HomeItalyZcube Launches 2024 Edition of Open Accelerator

Zcube Launches 2024 Edition of Open Accelerator

openaccelerator - zcube

Zcube – Zambon Research Venture launched the fifth edition of Open Accelerator, the international acceleration program for high-potential innovative startups in the field of life sciences.

Starting this year, the program will focus on the femtech sector and will feature a new format. The initiative invites startups and entrepreneurial ideas aimed at developing products and services to address major medical needs and improve women’s health and well-being. The targeted therapeutic areas include gynecology, cardiovascular health, oncology, sexual health, endocrinology, gastroenterology, nutrition, autoimmune disorders, mental health, neurology, reproductive health, and more.

The Call for application will open on Friday, March 8, 2024, on the International Women’s Day, and will remain open until June, 16.

At the end of the selection process, up to 5 startups will be identified to receive an investment of €100k each, through a SAFE (Simple Agreement for Future Equity) agreement and will have access to a training and mentoring program delivered by experts in the fields of investments, business development, venture capital, intellectual property, regulatory affairs, and market access.

Startups with the highest potential will also have the opportunity to build a partnership with the Zambon group, accelerating their market access phase and commercial positioning on a global scale.

The previous four editions of the program selected 46 startups from 23 countries, 8 of which have received up to €100k each in seed investment

Coordinating Open Accelerator will be a team of professionals experienced in Life Sciences and Venture Capital including Federica Destro, External Innovation & Community manager at Zcube, Vittoria Pavoncello, Technology Scouting & Investment Specialist at Zcube, Michele Gaiotto, CEO of HTH and Advisor to Zcube, and Marco Gullà, Investment Associate at HTH.

VCWire

01/03/2024